These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28392175)

  • 1. Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition.
    Lin W; Mandal S; Degen D; Liu Y; Ebright YW; Li S; Feng Y; Zhang Y; Mandal S; Jiang Y; Liu S; Gigliotti M; Talaue M; Connell N; Das K; Arnold E; Ebright RH
    Mol Cell; 2017 Apr; 66(2):169-179.e8. PubMed ID: 28392175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibiotic sorangicin A inhibits promoter DNA unwinding in a
    Lilic M; Chen J; Boyaci H; Braffman N; Hubin EA; Herrmann J; Müller R; Mooney R; Landick R; Darst SA; Campbell EA
    Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30423-30432. PubMed ID: 33199626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Chemical Scaffolds for Inhibition of Rifamycin-Resistant RNA Polymerase Discovered from High-Throughput Screening.
    Scharf NT; Molodtsov V; Kontos A; Murakami KS; Garcia GA
    SLAS Discov; 2017 Mar; 22(3):287-297. PubMed ID: 28027449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3).
    Lin W; Das K; Degen D; Mazumder A; Duchi D; Wang D; Ebright YW; Ebright RY; Sineva E; Gigliotti M; Srivastava A; Mandal S; Jiang Y; Liu Y; Yin R; Zhang Z; Eng ET; Thomas D; Donadio S; Zhang H; Zhang C; Kapanidis AN; Ebright RH
    Mol Cell; 2018 Apr; 70(1):60-71.e15. PubMed ID: 29606590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-inhibition as a strategic therapeutic approach to overcome rifampin resistance in tuberculosis therapy: atomistic insights.
    Agoni C; Ramharack P; Soliman ME
    Future Med Chem; 2018 Jul; 10(14):1665-1675. PubMed ID: 29957065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of Multi-Subunit
    Monama MZ; Olotu F; Tastan Bishop Ö
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
    Gill SK; Garcia GA
    Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid molecular detection of tuberculosis and rifampin resistance.
    Boehme CC; Nabeta P; Hillemann D; Nicol MP; Shenai S; Krapp F; Allen J; Tahirli R; Blakemore R; Rustomjee R; Milovic A; Jones M; O'Brien SM; Persing DH; Ruesch-Gerdes S; Gotuzzo E; Rodrigues C; Alland D; Perkins MD
    N Engl J Med; 2010 Sep; 363(11):1005-15. PubMed ID: 20825313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.
    Mori G; Orena BS; Franch C; Mitchenall LA; Godbole AA; Rodrigues L; Aguilar-Pérez C; Zemanová J; Huszár S; Forbak M; Lane TR; Sabbah M; Deboosere N; Frita R; Vandeputte A; Hoffmann E; Russo R; Connell N; Veilleux C; Jha RK; Kumar P; Freundlich JS; Brodin P; Aínsa JA; Nagaraja V; Maxwell A; Mikušová K; Pasca MR; Ekins S
    Tuberculosis (Edinb); 2018 Sep; 112():98-109. PubMed ID: 30205975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for transcription initiation by bacterial ECF σ factors.
    Li L; Fang C; Zhuang N; Wang T; Zhang Y
    Nat Commun; 2019 Mar; 10(1):1153. PubMed ID: 30858373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis.
    Molodtsov V; Scharf NT; Stefan MA; Garcia GA; Murakami KS
    Mol Microbiol; 2017 Mar; 103(6):1034-1045. PubMed ID: 28009073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three molecular assays for the detection of rifampin resistance in Mycobacterium tuberculosis.
    Moon HW; Hur M; Kim JY; Yun YM
    J Clin Lab Anal; 2015 Mar; 29(2):142-5. PubMed ID: 24797357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular insights into the mechanism of phenotypic tolerance to rifampicin conferred on mycobacterial RNA polymerase by MsRbpA.
    Dey A; Verma AK; Chatterji D
    Microbiology (Reading); 2011 Jul; 157(Pt 7):2056-2071. PubMed ID: 21415119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into RpoB clinical mutants in mediating rifampicin resistance in Mycobacterium tuberculosis.
    Nusrath Unissa A; Hassan S; Indira Kumari V; Revathy R; Hanna LE
    J Mol Graph Model; 2016 Jun; 67():20-32. PubMed ID: 27155814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed
    Wang W; Liu R; Yao C; Huo F; Shang Y; Zhang X; Wang Y; Xue Z; Ma L; Pang Y
    Microbiol Spectr; 2022 Feb; 10(1):e0208721. PubMed ID: 35107324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CarD and RbpA modify the kinetics of initial transcription and slow promoter escape of the Mycobacterium tuberculosis RNA polymerase.
    Jensen D; Manzano AR; Rammohan J; Stallings CL; Galburt EA
    Nucleic Acids Res; 2019 Jul; 47(13):6685-6698. PubMed ID: 31127308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Increasing the Affinity of CarD for RNA Polymerase on Mycobacterium tuberculosis Growth, rRNA Transcription, and Virulence.
    Garner AL; Rammohan J; Huynh JP; Onder LM; Chen J; Bae B; Jensen D; Weiss LA; Manzano AR; Darst SA; Campbell EA; Nickels BE; Galburt EA; Stallings CL
    J Bacteriol; 2017 Feb; 199(4):. PubMed ID: 27920294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
    Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
    BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis.
    Brandis G; Pietsch F; Alemayehu R; Hughes D
    J Antimicrob Chemother; 2015 Mar; 70(3):680-5. PubMed ID: 25362573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.